Alvelestat
Showing 1 - 4 of 4
Covid19 Trial in Birmingham (Alvelestat, Placebo)
Completed
- Covid19
- Alvelestat
- Placebo
-
Birmingham, AlabamaUAB Lung Health Center
Dec 21, 2022
Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute
Recruiting
- Chronic Graft vs Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Alpha-1 Antitrypsin Deficiency (AATD), Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either
Recruiting
- Alpha-1 Antitrypsin Deficiency (AATD)
- +2 more
- Alvelestat (MPH966)
- Placebo
-
Birmingham, Alabama
- +8 more
Aug 31, 2021
Hematologic Malignancy Trial in Durham (MPH966, Placebo)
Withdrawn
- Hematologic Malignancy
- MPH966
- Placebo
-
Durham, North CarolinaDuke University Adult Bone Marrow Transplant Clinic
Mar 18, 2020